Knowledge Network Node

BGEV样方案在复发/难治经典霍奇金淋巴瘤及弥漫大B细胞淋巴瘤中的应用探索

邢凌霄

南京医科大学

Abstract: Objective Up to 80%of patients with classical Hodgkin lymphoma（c HL）experience durable remissions after first-line therapy,but patients with relapsed/refractory c HL（R/R c HL）still present a poor prognosis.Autologous stem-cell transplantation （ASCT）after salvage therapy is the standard treatment option for R/R c HL after first-line therapy,and achieving complete remission（CR）is considered to be an important prognostic factor.This study aimed to investigate the efficacy and safety of BGEV regimen... More
Keywords：

classical Hodgkin lymphoma; BGEV; PD-1 antibody; autologous stem-cell transplantation; Diffuse large B-cell lymphoma; BGEV-like regimen;

  • Series：

    (E) Medicine ＆ Public Health

  • Subject：

    Oncology

  • DOI：

    10.27249/d.cnki.gnjyu.2023.001086

  • Classification Code：

    R733.1

Tutor：

李建勇;

Retraction:

内科学（血液病）（专业学位）

QRcode

Download the mobile appuse the app to scan this coderead the article.

Tips: Please download CAJViewer to view CAJ format full text.

Download: 22 Page: 59 Size: 1092k

Related Literature
  • Similar Article
  • Reader Recommendationr
  • Citation Network
  • Study Results